Home > Annual Financials > INDO US BIOTECH

INDO US BIOTECH Financial Statement Analysis
[BOM: 541304]

The Revenues of INDO US BIOTECH have increased by 23.36% YoY .
The Earnings Per Share (EPS) of INDO US BIOTECH has increased by 26.44 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

INDO US BIOTECH Last 5 Annual Financial Results
[BOM: 541304]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹62 Cr₹50 Cr₹40 Cr₹40 Cr₹35 Cr
Expenses ₹52 Cr₹43 Cr₹35 Cr₹36 Cr₹32 Cr
Operating Profit (Excl OI) ₹9.39 Cr₹6.93 Cr₹5.51 Cr₹3.96 Cr₹3.42 Cr
Other Income ₹0.02 Cr₹0.18 Cr₹0.04 Cr₹0.01 Cr₹0.03 Cr
Interest ₹1.20 Cr₹1.20 Cr₹1.18 Cr₹0.88 Cr₹0.40 Cr
Depreciation ₹0.83 Cr₹0.42 Cr₹0.25 Cr₹0.21 Cr₹0.24 Cr
Profit Before Tax ₹7.39 Cr₹5.49 Cr₹4.13 Cr₹2.86 Cr₹2.81 Cr
Profit After Tax ₹7.24 Cr₹5.24 Cr₹5.10 Cr₹2.54 Cr₹2.09 Cr
Consolidated Net Profit ₹7.24 Cr₹5.24 Cr₹5.10 Cr₹2.54 Cr₹2.09 Cr
Earnings Per Share (Rs)₹7.22₹5.71₹8.40₹4.18₹4.30
PAT Margin (%)11.7310.4612.726.375.88
ROE(%)15.5117.3426.8716.7422.21
ROCE(%)14.6215.8618.3016.6520.35
Total Debt/Equity(x)0.210.320.530.520.45

Key Financials

Market Cap : ₹ 454.3 Cr
Revenue (TTM) : ₹ 72.6 Cr
Net Profit(TTM) : ₹ 9.1 Cr
EPS (TTM) : ₹ 4.5
P/E (TTM) : 49.9

Industry Peers & Returns1W1M1Y
INDO US BIOTECH -2.2% 6.2% 252.6%
BOMBAY BURMAH TRADING CORPORATION -0.2% 0.4% 63.8%
KAVERI SEED COMPANY 15.8% 38.5% 70.7%
VENKYS (INDIA) 1.4% 13.2% 17.8%
BOMBAY SUPER HYBRID SEEDS -1.6% 6.1% -38.7%
TIERRA AGROTECH 3.9% 15.8% -41.6%
NATH BIOGENES (INDIA) 4.6% 16.9% 31.2%
MANGALAM SEEDS 2.8% 7.3% 38.7%
SHREE OSWAL SEEDS AND CHEMICALS 5.8% -6.9% -49.4%


INDO US BIOTECH Revenues
[BOM: 541304]

Y-o-Y

23.36 %

5 Yr CAGR

14.85 %

Years Revenues % Change
Mar2023 ₹62 Cr
23.36
Mar2022 ₹50 Cr
24.86
Mar2021 ₹40 Cr
0.82
Mar2020 ₹40 Cr
12.03
Mar2019 ₹35 Cr -


INDO US BIOTECH Operating Profit
[BOM: 541304]

Y-o-Y

35.52 %

5 Yr CAGR

28.73 %

Years Operating Profit % Change
Mar2023 ₹9.39 Cr
35.52
Mar2022 ₹6.93 Cr
25.70
Mar2021 ₹5.51 Cr
39.10
Mar2020 ₹3.96 Cr
15.91
Mar2019 ₹3.42 Cr -

Operating Margins
Y-o-Y

9.82 %

5 Yr CAGR

12.08 %

Years Operating Margin% % Change
Mar2023 15.21%
9.82
Mar2022 13.85%
0.65
Mar2021 13.76%
38.01
Mar2020 9.97%
3.42
Mar2019 9.64% -

INDO US BIOTECH Profit After Tax
[BOM: 541304]

Y-o-Y

38.25 %

5 Yr CAGR

36.46 %

Years Profit After Tax % Change
Mar2023 ₹7.24 Cr
38.25
Mar2022 ₹5.24 Cr
2.73
Mar2021 ₹5.10 Cr
101.10
Mar2020 ₹2.54 Cr
21.41
Mar2019 ₹2.09 Cr -

PAT Margins
Y-o-Y

12.14 %

5 Yr CAGR

18.84 %

Years PAT Margin(%) % Change
Mar2023 11.73 %
12.14
Mar2022 10.46 %
-17.77
Mar2021 12.72 %
99.69
Mar2020 6.37 %
8.33
Mar2019 5.88 % -

INDO US BIOTECH Earnings Per Share (EPS)
[BOM: 541304]

Y-o-Y

26.44 %

5 Yr CAGR

13.83 %

Years EPS % Change
Mar2023 ₹7.22
26.44
Mar2022 ₹5.71
-32.02
Mar2021 ₹8.40
100.96
Mar2020 ₹4.18
-2.79
Mar2019 ₹4.30 -

INDO US BIOTECH Return on Capital Employed (ROCE)
[BOM: 541304]

Y-o-Y

-7.82 %

5 Yr CAGR

-7.93 %

Years ROCE % Change
Mar2023 14.62%
-7.82
Mar2022 15.86%
-13.33
Mar2021 18.3%
9.91
Mar2020 16.65%
-18.18
Mar2019 20.35% -

INDO US BIOTECH Share Price vs Sensex

Current Share Price : ₹226.0
Current MarketCap: ₹ 454.3 Cr
Updated EOD on :Apr 29,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-2.2%

6.2%

252.6%

SENSEX

1.4%

2.5%

24.3%

INDO US BIOTECH related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about INDO US BIOTECH Financials


How the annual revenues of INDO US BIOTECH have changed ?

The Revenues of INDO US BIOTECH have increased by 23.36% YoY .

How the Earnings per Share (EPS) of INDO US BIOTECH have changed?

The Earnings Per Share (EPS) of INDO US BIOTECH has increased by 26.44 % YoY .